Just days after closing its neurosciences research unit in Shanghai, GlaxoSmithKline PLC announced a collaboration with China's e-commerce giant Alibaba leveraging Alibaba's online-to-offline (O2O) platform to promote GSK vaccines for adults.
GSK Bets On Online-To-Offline Push To Expand Reach In China
GSK’s alliance with AliHealth underscores its belief that the China market has significant room for growth if combined with the right technologies.
More from Drug Pricing
More from Scrip
• By
The biotech has rejected a takeover bid from Nordic Capital but a sale to private equity could be a solution to the public market's continued reluctance to adequately value PureTech’s hub-and-spoke business model.
Recent moves in the industry include C-suite changes at 23andMe, Biomea Fusion & Alector, plus Bicycle Therapeutics acquires chief medical officer from ImmunoGen.
• By
Menarini's Asia-Pacific CEO talks to Scrip about how the Italian group is tailoring its portfolio and pricing approach to local markets making strong strides in primary care and consumer health, while also charting a distinct path in rare diseases and oncology. The China market is also a key focus including as a potential source of innovation as is partnering, where the group has a rich history.